论文信息 - Predisposition or Protection? - 字舞流文

Predisposition or Protection?

A. Lala | E. Rashed | S. Pinney | V. Chau | A. Parikh | A. Singhvi | S. Jacobs | E. Oliveros | K. Mahmood | Taylor Hermle

[1] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[2] M. Cascella,et al. Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[3] Yuan Wei,et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[4] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[5] I. L. Pieper,et al. The Inflammatory Response to Ventricular Assist Devices , 2018, Front. Immunol..

[6] Peter W. Hunt,et al. HIV and Inflammation: Mechanisms and Consequences , 2012, Current HIV/AIDS Reports.

[7] Lewis H Kuller,et al. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[8] Yun-zhen Cao,et al. Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9] V. Wong,et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.